Receiving protocol: hospital pharmacy SOP template.

This page is written for a hospital pharmacy's receiving function. It describes the standard operating procedure we expect a receiving pharmacy to follow for an incoming Reserve Meds shipment, and it is intended to be adaptable into the receiving hospital's own SOP library. A hospital pharmacy receiving specialty product from a cross-border coordinator is, in effect, acting as the last control point on a long chain of custody, and the quality of the receiving protocol is a meaningful contributor to the quality of the therapy the patient ultimately receives.

Before the shipment arrives

The receiving pharmacy is briefed by our case-coordination team in advance of shipment departure. The briefing identifies the therapy, the pack configuration, the expected arrival window, the temperature class, the shipper and logger identifiers, and the name of the treating prescriber who has ordered the therapy. Documentation is made available electronically, including the prescription, the medical-necessity letter, the import-authorization documentation, and the DSCSA transaction records. The receiving pharmacist reviews the documentation before arrival so that the physical inspection at receipt can focus on what the physical inspection is for.

Incoming shipment inspection

On arrival, the receiving pharmacist performs a structured inspection of the outer packaging. The inspection confirms that the outer carton is intact with no visible damage, that seals are unbroken, that the shipping labels match the advance documentation, and that any visual indicators of mishandling, including tilt or shock indicators where the shipper carries them, are within tolerance. The outer carton is opened in a clean, controlled-temperature receiving area. The inner packaging is inspected for integrity before any product is handled.

Temperature-log verification

The temperature logger is retrieved and its data downloaded immediately. The data trace is compared against the temperature range validated for the product, not against a generic rule. Where the logger supports it, the trace is archived to the case record directly; where the download requires a USB or NFC handoff, the receiving pharmacist captures the trace and attaches it to the case. A trace that is within the validated envelope supports proceeding; a trace that contains any excursion outside the validated envelope triggers the quarantine protocol described below. The receiver does not proceed to dispensing until the trace has been reviewed.

Chain-of-custody reconciliation

The receiving pharmacist reconciles three sets of identifiers. The first is the serial number on the product package, which is compared against the advance documentation; any discrepancy is flagged to us immediately. The second is the DSCSA transaction record that accompanies the unit, which is reconciled against the expected lot and pack configuration. The third is the import-authorization documentation, which must match the product identity and the patient identity on the prescription. A clean reconciliation is a pre-requisite for accepting the unit into the dispensing inventory.

Quarantine-until-cleared

Any unit that fails any element of the incoming inspection is quarantined. Quarantine means physical separation from the dispensing inventory in a labeled, locked, environmentally-controlled location, with a written hold note on the case record. The receiving pharmacist contacts our case-coordination team to report the issue, and no further action is taken until we have reviewed the case and issued a written disposition. Typical dispositions include release to dispensing after a minor excursion has been reviewed against the manufacturer's stability data and found within envelope, quarantine and replacement at our cost where the excursion is outside envelope, and return for documentation re-verification where the paperwork requires clarification. The receiving pharmacy does not carry the cost or the decision burden of a quarantined unit.

Patient-match verification at dispensing

When the unit is released from quarantine or moves directly into the dispensing inventory, the receiving pharmacist performs a patient-match verification before dispensing. The verification confirms that the patient identified on the prescription matches the patient for whom the unit was imported under the named-patient authorization, that the prescriber on the prescription matches the prescriber who signed the medical-necessity letter, that the dose and schedule on the prescription match the treatment plan in the case record, and that the patient's administration is scheduled with the treating prescriber's team. Any mismatch is resolved before dispensing.

Documentation at dispense

At dispense, the receiving pharmacist records the dispense in the pharmacy's own system and returns a dispense confirmation to us. The confirmation closes the sourcing and logistics stage of the case and opens the delivery and follow-up stage. The receiving pharmacy retains the case documentation, including the temperature trace and the DSCSA transaction records, for the period local regulations require.

Adverse-event reporting from receiving pharmacy

If an adverse event is observed after administration and is reported back to the receiving pharmacy, the pharmacy routes the report to us at [email protected] in addition to any local pharmacovigilance route the hospital operates. Our case record, including the chain-of-custody and cold-chain documentation, is available to support causality assessment.

For a ready-to-use checklist

A condensed, printable version of the receiving protocol, suitable for posting at a hospital pharmacy receiving desk, is available at the receiving checklist. The checklist is intended to accompany this full SOP rather than replace it; the checklist captures the physical inspection steps, while this page provides the reasoning and the dispositions that the checklist presupposes.

Adapting this SOP to the receiving institution

Hospital systems with existing receiving SOPs can integrate the steps above into their own procedures. We are happy to walk a hospital's quality team through the protocol, to provide the documentation package a formal supplier qualification requires, and to commit to the receiving interface in a master services agreement where that is useful. See the enterprise section for how those relationships typically work.

Reviewed 2026-04-22 by Reserve Meds’s AI clinical and regulatory review agents. Human pharmacist-in-charge: Altima Care. Next scheduled review: 2026-10-22.